Isolation of Nbutylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives, and use of N-butylbenzenesulfonamide and benzenesulfonamide derivatives for the treatment of benign prostate hyperplasia and/or prostate carcinoma
Details for Australian Patent Application No. 2006210040 (hide)
International Classifications
Event Publications
23 August 2007 PCT application entered the National Phase
PCT publication WO2006/081994 Priority application(s): WO2006/081994
14 April 2011 Application Accepted
Published as AU-B-2006210040
11 August 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006210041-Device and method for the elimination of magnetic or magnetizable particles from a liquid
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser